Cargando…
Identification of Potential Biomarkers and Biological Pathways for Poor Clinical Outcome in Mucinous Colorectal Adenocarcinoma
SIMPLE SUMMARY: Patients with mucinous adenocarcinoma (MAC) have been considered to have a faster disease progression than patients with traditional adenocarcinoma (TAC) in colorectal cancer (CRC). However, to date, the roles of MAC in long-term survival remain controversial due to a small sample si...
Autores principales: | Kim, Chang Woo, Cha, Jae Myung, Kwak, Min Seob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268122/ https://www.ncbi.nlm.nih.gov/pubmed/34208938 http://dx.doi.org/10.3390/cancers13133280 |
Ejemplares similares
-
Prognostic Comparison Between Mucinous and Nonmucinous Adenocarcinoma in Colorectal Cancer
por: Park, Jong Seob, et al.
Publicado: (2015) -
Identification of a prognostic signature and ENTR1 as a prognostic biomarker for colorectal mucinous adenocarcinoma
por: Huang, An, et al.
Publicado: (2023) -
Clinicopathological and Molecular Features of Colorectal Cancer Patients With Mucinous and Non-Mucinous Adenocarcinoma
por: Lan, Yuan-Tzu, et al.
Publicado: (2021) -
Chasm between Public Perceptions and Epidemiological Data on Colorectal Cancer
por: Park, Su Bee, et al.
Publicado: (2023) -
Serrated adenocarcinoma morphology in colorectal mucinous adenocarcinoma is associated with improved patient survival
por: Lee, Chung-Ta, et al.
Publicado: (2017)